CopyMark Law Group
4.9/5
Drawing for CTM BIO CONCEPT TO MEDICINE

USPTO serial 79349197

CTM BIO CONCEPT TO MEDICINE

Reviewed by CopyMark Law Group

Reg. 7273014Status 700Registered
Filing date
Status date
Registration date
Jan 16, 2024
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CTM BIO CONCEPT TO MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of cancer; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations for treating livers; pharmaceutical preparations for treating lungs; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations acting on the central nervous system; dietetic foods adapted for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2024FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 17, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2024FIMPFINAL DISPOSITION PROCESSED—
Apr 16, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 31, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 11, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 14, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 14, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 4, 2023RFNTREFUSAL PROCESSED BY IB—
Jun 11, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 11, 2023RFRRREFUSAL PROCESSED BY MPU—
Apr 25, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 24, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2023DOCKASSIGNED TO EXAMINER—
Sep 20, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 8, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance